The Society Pages
Dorothea Zucker-Franklin, MD (1929-2015)
Dorothea Zucker-Franklin, MD, passed away on November 24, 2015, at the age of 86.
Dr. Zucker-Franklin was a highly respected hematologist and research scientist. She contributed to the
basis of contemporary cell biology through her work on
the microarchitecture of blood cells, including platelets,
lymphocytes, and megakaryocytes.
Dr. Zucker-Franklin was professor at NYU Medical
School and accrued professional accolades throughout
her distinguished career, including serving as president
of ASH in 1995 and induction into the Institute of Medicine that same year. In addition to numerous original
publications and public presentations, she co-authored
Lois Travis Named Leader of
Indiana University Cancer
Center
Raymond Bergan Named Chair
of ECOG-ACRIN Prevention
Committee
Lois B. Travis, MD, ScD,
has been appointed the
Lawrence H. Einhorn Professor of Cancer Research
at Indiana University
(IU) School of Medicine
and the director of the
Lois B. Travis, MD, ScD
new Cancer Survivorship
Research Program at the
IU Simon Cancer Center. She also will hold an
academic appointment in the Department of
Epidemiology at the IU Richard M. Fairbanks
School of Public Health. Previously, Dr. Travis
was the director of the Rubin Center for
Cancer Survivorship and chief of the Division
of Cancer Survivorship at the University of
Rochester Medical Center, as well as a senior
principal investigator and lead research investigator at the National Cancer Institute.
Raymond C. Bergan, MD,
the DeArmond Chair of
Cancer Research, chief of
the Division of Hematology and Medical Oncology,
and associate director for
Medical Oncology at the
Raymond C. Bergan, MD
Oregon Health & Science
University Knight Cancer
Institute, has been elected chair of the ECOGACRIN Cancer Research Group’s Prevention
Committee. The ECOG-ACRIN Prevention
Committee develops biomarker-driven trials
targeting patients who have been previously
successfully treated for a prior cancer yet are
at high risk for recurrence, as well as healthy
individuals at risk for developing cancer due
to the presence of premalignant disease. Dr.
Bergan succeeds Fadlo R. Khuri, MD, formerly
of Emory University, who resigned the position earlier this year to become president of
the American University of Beirut.
Source: Indiana University press release, August 12, 2015.
Nestor Esnaola Receives
Cancer Control Award from the
American Cancer Society
Nestor F. Esnaola, MD,
MPH, MBA, professor of
surgery and associate
director for Cancer Health
Disparities and Community Engagement at Fox
Chase Cancer Center-TemNestor F. Esnaola, MD,
ple Health, received the
MPH, MBA
2015 Cancer Control Award
from the American Cancer Society. Dr. Esnaola
was recognized for his efforts to define the
cancer burden faced by diverse communities,
promoting cultural competence among clinical providers and research staff and expanding clinical trials literacy.
Source: Fox Chase Cancer Center press release, September 8, 2015.
8
ASH Clinical News
a definitive atlas of hematology, Atlas of Blood Cells:
Function and Pathology. On a personal note, she married Edward C. Franklin, MD, in 1956, beginning the
warm and vivacious personal and professional partnership that lasted until his premature death in 1982.
Together they purchased and cared for their much loved
farm in the Berkshires, travelled internationally, collected pre-Columbian figurines, enjoyed many of New
York’s cultural offerings as well as a sabbatical year in
Paris, and developed a passion for downhill skiing.
In the January/February issue of The Hematologist,
there will be an In Memoriam article focusing on Dr.
Zucker-Franklin’s career.
Source: ECOG-ACRIN press release, September 15, 2015.
Bart Barlogie Joins Mount
Sinai’s Tisch Cancer Institute
Bart Barlogie, MD, has
joined the faculty of Tisch
Cancer Institute of the
Icahn School of Medicine
at Mount Sinai as the
director of research in the
Myeloma Program, which
Bart Barlogie, MD
is led by Sundar Jagannath, MD, professor of hematology and medical oncology at the Icahn
School of Medicine. In this new position, Dr.
Barlogie will continue to focus on biologic and
therapeutic research, including chemotherapy,
immunotherapy, and hematopoietic stem
cell transplantation in patients with highrisk myeloma. He has served for 20 years as
director of Myeloma Institute for Research &
Therapy at University of Arkansas for Medical
Sciences.
Source: Mount Sinai Health System press release, September 23, 2015.
UC San Diego Receives
NCI Grant to Study Cancer
Treatment Disparities
The National Cancer Institute has awarded
a $13 million, five-year grant to the Moores
Cancer Center at the University of California,
San Diego and San Diego State University to
establish a collaborative program aimed at
reducing cancer treatment disparities among
Hispanic and Latino patients. The program,
known as the SDSU/UCSD Cancer Center
Comprehensive Partnership, will support 30
joint research projects and research education programs for undergraduate students
of underrepresented racial and ethnic groups
who are studying cancer and cancer disparities. The program is headed by Maria Elena
Martinez, PhD, of the Moores Cancer Center,
and Elva Arredondo, PhD, of San Diego State
University.
Source: University of California press release, September 28, 2015.
NHGRI Leukemia Researcher
Receives Alumnus Award from
University of Texas
Paul Liu, MD, PhD
The Graduate School of
the University of Texas
Health Science Center at
Houston and the University of Texas MD Anderson
Cancer Center has named
Paul Liu, MD, PhD, as
its 2015 Distinguished
Alumnus. Dr. Liu is senior
January 2016